YU36515B - Process for obtaining hexyhydrodibenzo(b,d)-pyran - Google Patents

Process for obtaining hexyhydrodibenzo(b,d)-pyran

Info

Publication number
YU36515B
YU36515B YU02658/74A YU265874A YU36515B YU 36515 B YU36515 B YU 36515B YU 02658/74 A YU02658/74 A YU 02658/74A YU 265874 A YU265874 A YU 265874A YU 36515 B YU36515 B YU 36515B
Authority
YU
Yugoslavia
Prior art keywords
hexyhydrodibenzo
pyran
obtaining
obtaining hexyhydrodibenzo
Prior art date
Application number
YU02658/74A
Other languages
English (en)
Other versions
YU265874A (en
Inventor
Archer Allen Robert
Allen Robert Archer
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of YU265874A publication Critical patent/YU265874A/xx
Publication of YU36515B publication Critical patent/YU36515B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
YU02658/74A 1973-11-05 1974-10-02 Process for obtaining hexyhydrodibenzo(b,d)-pyran YU36515B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/413,010 US3968125A (en) 1973-11-05 1973-11-05 Dihydroxyhexahydrodibenzo[b,d]pyrans

Publications (2)

Publication Number Publication Date
YU265874A YU265874A (en) 1982-02-25
YU36515B true YU36515B (en) 1984-02-29

Family

ID=23635420

Family Applications (1)

Application Number Title Priority Date Filing Date
YU02658/74A YU36515B (en) 1973-11-05 1974-10-02 Process for obtaining hexyhydrodibenzo(b,d)-pyran

Country Status (26)

Country Link
US (1) US3968125A (xx)
JP (1) JPS6033835B2 (xx)
AR (1) AR202318A1 (xx)
AT (1) AT336012B (xx)
BE (1) BE821716A (xx)
BG (1) BG26387A3 (xx)
CA (1) CA1023753A (xx)
CH (1) CH605894A5 (xx)
CS (1) CS193507B2 (xx)
DD (1) DD116230A5 (xx)
DE (1) DE2451934C2 (xx)
DK (1) DK136719B (xx)
ES (1) ES431674A1 (xx)
FR (1) FR2249664B1 (xx)
GB (1) GB1487637A (xx)
HU (1) HU169193B (xx)
IE (1) IE40023B1 (xx)
IL (1) IL45644A (xx)
NL (1) NL7414439A (xx)
PH (1) PH11788A (xx)
PL (2) PL95748B1 (xx)
RO (1) RO71766A (xx)
SE (1) SE415762B (xx)
SU (1) SU524517A3 (xx)
YU (1) YU36515B (xx)
ZA (1) ZA745751B (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1522057A (en) * 1975-11-03 1978-08-23 Pfizer 9-hydroxydibenzo(b,d)pyrans and intermediates therefor
US4051152A (en) * 1976-01-07 1977-09-27 Sharps Associates Oxo C-ring benzopyrans
US4087546A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiasthmatic drugs
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
US4054581A (en) * 1976-07-06 1977-10-18 Eli Lilly And Company Preparation of cis-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones and intermediates therefor
US4133819A (en) * 1977-06-17 1979-01-09 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4209520A (en) * 1977-06-17 1980-06-24 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4243674A (en) * 1978-06-12 1981-01-06 Pfizer Inc. 9-Hydroxydibenzo[b,d]pyrans and intermediates therefore
US4454144A (en) * 1982-06-21 1984-06-12 Pfizer Inc. Substituted dibenzo[b,d]pyran analgesics
JPS6299930U (xx) * 1985-12-12 1987-06-25
US8449908B2 (en) * 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
JP4202250B2 (ja) 2001-07-25 2008-12-24 バイオマリン ファーマシューティカル インコーポレイテッド 血液脳関門輸送を調節するための組成物および方法
US20050101590A1 (en) 2002-02-19 2005-05-12 Kiyoshi Yasui Antipruritics
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
CA2663377A1 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
EP2176208B1 (en) * 2007-07-30 2015-01-21 Zynerba Pharmaceuticals, Inc. Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same
EP2254601B1 (en) 2008-02-08 2019-05-29 Nektar Therapeutics Oligomer-cannabinoid conjugates
US20090247619A1 (en) * 2008-03-06 2009-10-01 University Of Kentucky Cannabinoid-Containing Compositions and Methods for Their Use
EP2398500B1 (en) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Glutathione-based drug delivery system
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
US20200197357A1 (en) 2017-07-20 2020-06-25 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions and methods of lipophilic drugs
WO2019049145A1 (en) 2017-09-11 2019-03-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. COMPOSITIONS AND METHODS FOR NASAL BRAIN MEDICATION ADMINISTRATION FOR SYSTEMIC EFFECT
EP3717014A1 (en) 2017-11-29 2020-10-07 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Cannabinoids compositions and methods
WO2020089905A1 (en) 2018-11-04 2020-05-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Orally administrable cannabinoids-containing compositions and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507885A (en) * 1966-03-25 1970-04-21 Hoffmann La Roche 3-alkyl-6h-dibenzo(b,d)pyrans
US3636058A (en) * 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones
CH558792A (de) * 1971-10-14 1975-02-14 Petrzilka Theodor Verfahren zur herstellung von tetrahydrodibenzopyranen.

Also Published As

Publication number Publication date
ES431674A1 (es) 1976-11-16
DE2451934A1 (de) 1975-05-07
SU524517A3 (ru) 1976-08-05
NL7414439A (nl) 1975-05-07
CS193507B2 (en) 1979-10-31
ATA886374A (de) 1976-08-15
IE40023B1 (en) 1979-02-28
DK136719C (xx) 1978-04-24
IL45644A0 (en) 1974-11-29
PL95748B1 (pl) 1977-11-30
FR2249664A1 (xx) 1975-05-30
DK136719B (da) 1977-11-14
PH11788A (en) 1978-07-05
IE40023L (en) 1975-05-05
RO71766A (ro) 1982-12-06
GB1487637A (en) 1977-10-05
HU169193B (xx) 1976-10-28
BG26387A3 (bg) 1979-03-15
JPS6033835B2 (ja) 1985-08-05
US3968125A (en) 1976-07-06
SE7413833L (xx) 1975-05-06
CH605894A5 (xx) 1978-10-13
BE821716A (fr) 1975-04-30
ZA745751B (en) 1976-04-28
DD116230A5 (xx) 1975-11-12
CA1023753A (en) 1978-01-03
AU7321274A (en) 1976-03-18
YU265874A (en) 1982-02-25
DE2451934C2 (de) 1983-10-06
DK573274A (xx) 1975-07-07
SE415762B (sv) 1980-10-27
AR202318A1 (es) 1975-05-30
AT336012B (de) 1977-04-12
PL93908B1 (xx) 1977-07-30
FR2249664B1 (xx) 1978-03-24
JPS5071678A (xx) 1975-06-13
IL45644A (en) 1978-03-10

Similar Documents

Publication Publication Date Title
YU36515B (en) Process for obtaining hexyhydrodibenzo(b,d)-pyran
YU128774A (en) Process for preparing triazolyl-o,n-acetals
YU36946B (en) Process for obtaining hexahydro-dibenzo(b,d)-pyrane-9-one compounds
YU127874A (en) Process for obtaining compolyamides
YU39152B (en) Process for obtaining 4-hydroxy-1,2-benzothiazine-3-carboxylamides
YU285474A (en) Process for preparing new n-methoxymethyl-furyl-methyl)-6,7-benzomorphans and - morphinans
YU36948B (en) Process for obtaining piperazinyl-quinazolines
YU235174A (en) Process for preparing dodeca-7,9-diene-1-yl-acetate
YU39604B (en) Process for obtaining new 3-phenyl-6-halopyridazine
YU296680A (en) Process for obtaining new d-homosteroids
YU88174A (en) Process for obtaining 2-arylamino-2-imidazoline derivativees
YU37346B (en) Process for obtaining 14beta-alkyloxamorphinane
YU39303B (en) Process for obtaining alfa-6-deoxy-tetracyclines
YU39722B (en) Process for obtaining 0,0-diethyldithio-phoshoryl-methyl-3-chloro-6-benzoxazolone
YU39915B (en) Process for obtaining 6-alfa-deoxy-5-hydroxytetracycline
YU37154B (en) Process for obtaining new 2,4-diaminobenzyl-pyrimidines
YU36922B (en) Process for obtaining new m-diurethanes
YU91174A (en) Process for obtaining n-phenyl-n-1,23-thiadiazol-5-yl thiocarbamide
CS186280B2 (en) Method for producing 6-fluoralkyl-2,3-quinoxaline diones
YU206774A (en) Process for obtaining 3,4-diamino-benzophenones
YU36941B (en) Process for obtaining new thiadizolyl-carbamides
YU279774A (en) Process for obtaining 4-oxo-2-imidazolidinylidene-urea
YU36520B (en) Process for obtaining new thiadiazolylimidazolidinones
CS193096B2 (en) Process for preparing 2-nitroindan-1,3-diones
YU36009B (en) Process for obtaining 4-acetamido-phenyl-2-acetoxybenzoate